Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
Tóm tắt
In vitro cell lines were established from seven biologically distinct in vivo Dunning R3327 rat prostatic tumor sublines. Some of these in vitro cell lines (i.e., G, AT‐1, AT‐2) retain a low metastatic ability when inoculated back into syngeneic Copenhagen male rats, while others (i.e., AT‐3, MAT‐LyLu, MAT‐Lu) retain a very high metastatic ability. A series of genetic (i.e., DNA content per cell, modal chromosomal number), as well as phenotypic parameters (i.e., morphology, 5α‐reductase, androgen receptor, estrogen receptor) were used to validate that the in vitro cell lines retained the major characteristics of the parental in vivo tumor sublines used for their respective establishment.
A series of additional characteristics (i.e., morphology, growth rate, saturation density in surface culture, anchorage‐dependent and ‐independent clonogenic potential) were compared between the high vs. the low metastatic in vitro cell lines to determine if a discriminatory parameter could be identified which reproducibly predicted the metastatic abilities of the particular prostatic cancer cell line. While the combination of the in vitro cell lines and their parental in vivo tumor subline will be a valuable tool for developing methods for predicting metastatic ability of prostate cancers, no single parameter yet measured is entirely successful in making this important distinction.
Từ khóa
Tài liệu tham khảo
Catalona WJ, 1979, Campbell's Urology, 1085
Diamond DA, 1982, New method to assess metastatic potential of human prostate cancer: Relative nuclear roundness, J Urol, 128, 727, 10.1016/S0022-5347(17)53158-4
Lowe FC, 1984, Biochemical methods for predicting metastatic ability of prosatic cancer utilizing the Dunning R‐3327 rat prostatic adenocarcinoma system as a model, Cancer Res, 44, 744
Isaacs JT, 1983, Model systems for the study of prostatic cancer, Clinics in Oncology, 2, 479
Dunning WF, 1963, Prostate cancer in the rat, Monographs of the National Cancer Institute, 12, 351
Smolev J, 1977, Characterization of the Dunning R‐3327‐H prostatic adenocarcinoma: An appropriate animal model for prostate cancer, Cancer Treat Rep, 61, 273
Isaacs JT, 1981, Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R‐3327‐H adenocarcinoma, Cancer Res, 41, 5070
Isaacs JT, 1978, Animal models of the hormone‐sensitive and ‐ insensitive prostatic adenocarcinomas, Dunning R‐3327‐H, R‐3327‐HI, and R‐3327‐AT, Cancer Res, 38, 4353
Isaacs JT, 1982, Genetic instability coupled to clonal selection as a mechanism for progression in prostatic cancer, Cancer Res., 42, 2353
Isaac JT, 1981, The characterization of a newly identified, highly metastatic variant of the Dunning R‐3327 rat prostatic adenocarcinoma system: The MAT‐LyLu tumor, Invest Urol, 19, 20
Lazan D, 1982, Inhibition of the R3327 MAT‐Lu prostatic tumor by diethylstilbestrol and 1,2‐bis(3,5‐dioxopiperazin‐1‐yl)propane, Cancer Res, 42, 1390
McKeehan WL, 1984, Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum‐free, primary cell culture, Cancer Res, 44, 1998
Wake N, 1982, Chromosomal changes associated with progression of the Dunning R‐3327 rat prostatic adenocarcinoma system, Cancer Res, 42, 4131
Vindelov LL, 1977, Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspension, Virchows Arch B [Cell Path], 24, 227, 10.1007/BF02889282
Isaacs JT, 1979, Models for development of nonreceptor methods for distinguishing androgen‐sensitive and ‐insensitive prostatic tumors, Cancer Res, 39, 2652
Shain SA, 1984, Biochemical and morphological characterization of clonal AXC rat prostate cancer cells, Cancer Res, 44, 2033
Sestili MA, 1983, Isolation and characterization of a cloned cell line R‐3327‐G8‐A1 derived from the Dunning R3327‐H rat adenocarcinoma, Cancer Res, 43, 2162
Pollack A, 1982, Hormone sensitivity of the R3327‐G rat prostatic adenocarcinoma: Growth rate, DNA content, and hormone receptors, Cancer Res, 42, 2184